Cited by 1,077Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 195 of the 196 references it cites were found in a registry or an index.

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Open access

Neuschwander‐Tetri, Brent A.·2010·Hepatology

Open this paper in CoChat — free account Open PDF

Abstract

A significant body of evidence now forces us to rethink the causes of NASH. Once thought to be a disease caused by triglyceride accumulation in hepatocytes with subsequent oxidant stress and lipid peroxidation causing inflammation and fibrosis, new data from animal studies and a limited number of human studies now provide convincing evidence that triglyceride accumulation does not cause insulin resistance or cellular injury in the liver. The lipotoxic liver injury hypothesis for the pathogenesis of NASH suggests that we need to focus our therapeutic efforts on reducing the burden of fatty acids going to the liver or being synthesized in the liver. This can be accomplished by improving insulin sensitivity at the level of adipose tissue to prevent inappropriate peripheral lipolysis and by preventing unnecessary de novo lipogenesis in the liver. Excess carbohydrates are the major substrates for de novo lipogenesis, and thus, reducing carbohydrate consumption through dietary changes and increasing muscle glucose uptake through exercise remain important cornerstones of treatment and prevention of lipotoxic liver injury, a disease hitherto called NASH.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.23719

Cites

195 of 195 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338

Flagged first, then by citations

Show all 196 references

1 of the 196 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 997

La Estoria de España de Alfonso X: creación y evolución
Catalán, D. (1992) · Cited by 13
Excess cholesterol and fat in the diet: A dangerous liaison for energy expenditure and the liver
Neuschwander‐Tetri, B. A., & Wang, D. Q. ‐. (2012) · Hepatology · doi:10.1002/hep.25953 · Cited by 13
Self-citation
Non-alcoholic fatty liver disease
Verhaegh, P. L. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210428pv · Cited by 13
Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
Laursen, T. L., Mellemkjær, A., Møller, H. J., Grønbæk, H., & Kazankov, K. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2132145 · Cited by 12
Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease
Liu, J., Wang, T., Yang, F., & Pubu, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1642436 · Cited by 13
Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
Che, W., Zhao, M., Li, X., Li, C., Cho, W. C. S., & Yu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1002916 · Cited by 12
Comparison of prepartum blood parameters in dairy cows with postpartum ketosis and new risk prediction candidates
Choi, W., Ro, Y., Choe, E., Hong, L., Kim, D., Kim, S., Yoon, I., & Kim, D. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1161596 · Cited by 12
Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
Apalowo, O. E., Adegoye, G. A., & Obuotor, T. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46030119 · Cited by 13
Mixed exposure to haloacetaldehyde disinfection by-products exacerbates lipid aggregation in the liver of mice
Qiu, M., Yang, L., Jiang, Z., Chen, Y., Liu, Q., Wang, X., & Qu, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123971 · Cited by 12
Regulation of hepatic lipogenesis by asymmetric arginine methylation
Han, H.-S., Choi, B. H., Jang, S. Y., Choi, S., Hwang, G., & Koo, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155938 · Cited by 12
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
Cammisotto, V., Valeriani, E., Pignatelli, P., & Violi, F. (2025) · Antioxidants · doi:10.3390/antiox14010083 · Cited by 12
Pharmacological therapy for non‐alcoholic steatohepatitis: How efficient are thiazolidinediones?
Ratziu, V., & Pienar, L. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00825.x · Cited by 12
Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
Tu, C., Xu, Z., Tian, L., Yu, Z., Wang, T., Guo, Z., Zhang, J., & Wang, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.700120 · Cited by 13
Effects of Keemun and Dianhong Black Tea in Alleviating Excess Lipid Accumulation in the Liver of Obese Mice: A Comparative Study
Liao, W., Liu, S., Chen, Y., Kong, Y.-S., Wang, D., Wang, Y., Ling, T.-J., Xie, Z., Khalilova, I. S., & Huang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.849582 · Cited by 12
Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”
Siemienowicz, K. J., Filis, P., Thomas, J. L., Fowler, P., Duncan, W. C., & Rae, M. T. (2022) · Biomedicines · doi:10.3390/biomedicines10061291 · Cited by 12
Fluorescing fatty acids in rat fatty liver models
Croce, A. C., Ferrigno, A., Pasqua, L. G. D., Berardo, C., Mannucci, B., Bottiroli, G. F., & Vairetti, M. (2016) · Journal of Biophotonics · doi:10.1002/jbio.201600195 · Cited by 12
Antihypercholesterolemic Effects of Fruit Aqueous Extract of Copernicia prunifera (Miller) H. E. Moore in Mice Diet‐Induced Hypercholesterolemia
Paim, R. T. T., Benjamin, S. R., Rondina, D., Marques, M. M. M., Viana, D. D. A., Gonzaga, M. L. D. C., Vieira, Í. G. P., Mendes, F. N. P., Rodrigues, P. A. S., & Guedes, M. I. F. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/6376173 · Cited by 12
Sexual dimorphism in hepatic lipids is associated with the evolution of metabolic status in mice
Soares, A. F., Montoya, J. P., Lei, H., Moniatte, M., & Rolf Gruetter, A. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3761 · Cited by 12
Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
Kjær, M. B., George, J., Kazankov, K., & Grønbæk, H. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1817740 · Cited by 13
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals
Cho, I. Y., Chang, Y., Sung, E., Kang, J., Shin, H. C., Wild, S. H., Byrne, C. D., & Ryu, S. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.04.037 · Cited by 12
THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL
TAGLIARI, E., Campos, A. C. L., Costa-Casagrande, T. A., & Salvalaggio, P. R. O. (2017) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201700030011 · Cited by 12
Proteomics for studying the effects of L. rhamnosus LV108 against non-alcoholic fatty liver disease in rats
Qu, H., Yu, H., Gu, R., Chen, D., Chen, X., Huang, Y., Xi, W., & Huang, Y. (2018) · RSC Advances · doi:10.1039/c8ra06771f · Cited by 12
New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut–liver axis impairment
Aron‐Wisnewsky, J., & Pépin, J. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207212 · Cited by 12
FGF21: A Sharp Weapon in the Process of Exercise to Improve NAFLD
Wang, Z., Sun, T., Yu, J., Li, S., Gong, L., & Zhang, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812351 · Cited by 12
Chronic exposure to 3,6-dichlorocarbazole exacerbates non-alcoholic fatty liver disease in zebrafish by disrupting lipid metabolism and inducing special lipid biomarker accumulation
Hou, C., Huang, M., Wang, P., Zhang, Q., Wang, G., & Gao, S. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.141442 · Cited by 11
The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
Yaghmaei, H., Bahanesteh, A., Soltanipur, M., Takaloo, S., Rezaei, M., & Siadat, S. D. (2024) · International Journal of Hepatology · doi:10.1155/2024/4183880 · Cited by 11
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES
Li, B., Liu, Y., Ma, X., & Guo, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-90773-y · Cited by 11
Emerging Roles of Periodontal Pathogen–Derived Outer Membrane Vesicles in NAFLD
Lv, C., Shi, K., Guo, Y.-D., Guo, Z., Luo, P., Wang, L., Wu, Z., & Yu, P. L. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.03.029 · Cited by 11
The Liver in Diabetes and Metabolic Syndrome
Mahmoud, M. C., & Abdelmalek, M. F. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.04.003 · Cited by 14
The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH
Abdelrahman, B. A., Hammam, O. A., El-Khatib, A. S., & Attia, Y. M. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149122 · Cited by 11
Recent advances in understanding/management of non-alcoholic steatohepatitis
Pacana, T., & Sanyal, A. J. (2015) · F1000Prime Reports · doi:10.12703/p7-28 · Cited by 13
Treatment with Rhodiola crenulata root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal muscle
Chen, T., Yao, L., Ke, D., Cao, W., Zuo, G., Zhou, L. F., Jiang, J. W., Yamahara, J., Li, Y., & Wang, J. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1176-z · Cited by 11
Obesity and Nonalcoholic Fatty Liver Disease
Bullón‐Vela, V., Abete, I., Martínez, J. A., & Zulet, M. Á. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00006-4 · Cited by 12
Application of a Novel Mass Spectral Data Acquisition Approach to Lipidomic Analysis of Liver Extracts from Sitaxentan-Treated Liver-Humanized PXB Mice
King, A. M., Baginski, M., Morikawa, Y., Rainville, P. D., Gethings, L. A., Wilson, I. D., & Plumb, R. S. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00334 · Cited by 11
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Leiva, E. G., & Bril, F. (2020) · Current Hypertension Reviews · doi:10.2174/1573402116999201209203534 · Cited by 11
Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver–heart crosstalk
Njoku, D. B., Schilling, J. D., & Finck, B. N. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000845 · Cited by 10
Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH
Fraser, D. A., Harrison, S. A., & Schuppan, D. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2159804 · Cited by 11
Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
Kholodenko, I. V., & Yarygin, K. N. (2023) · Biomedicines · doi:10.3390/biomedicines11113056 · Cited by 14
A scientifically validated combination of garcinol, curcuminoids, and piperine for mild to moderate nonalcoholic steatohepatitis patients—results from a randomized, double-blind, placebo-controlled study
Majeed, M. A., Nagabhushanam, K., Noureddin, M., Paulose, S., Barik, C., Saklecha, S., & Mundkur, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1201186 · Cited by 10
DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis
Lee, D., Jo, S. H., Lee, E. S., Ha, K. B., Park, N. W., Kong, D.-H., Park, S., Park, J. S., & Chung, C. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0367 · Cited by 10
Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesicles
Liao, T., Chen, D.-Y., Hsieh, S.-L., Yang, Y., Chen, Y., Tang, K., Chang, C., & Yang, S. (2024) · Hepatology · doi:10.1097/hep.0000000000001149 · Cited by 10
Obesity-induced chronic low grade inflammation: Gastrointestinal and adipose tissue crosstalk
Magnuson, A. M., Fouts, J. K., Booth, A. D., & Foster, M. T. (2015) · Integrative Obesity and Diabetes · doi:10.15761/iod.1000124 · Cited by 10
Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1–7)/Mas axis-mediated anti-inflammatory pathway in rats
Wang, C., Ren, L., Chen, S., Zheng, H., Yang, Y., Gu, T., Li, Y., & Wang, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114072 · Cited by 10
Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
Song, J., Baek, I., Park, S., Oh, J., Kim, D., Song, K., Kim, M. K., Lee, H. W., Jang, B. K., & Jin, E. (2022) · iScience · doi:10.1016/j.isci.2022.105135 · Cited by 11
ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation
Kong, D., Mai, Z., Chen, Y., Luo, L., Liu, H., Le, Z., Huang, R., Wang, S., Chen, R., Zhou, H., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15121526 · Cited by 11
Glitazones for human nonalcoholic steatohepatitis
Pais, R., Moraru, I., & Ratziu, V. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11409793 · Cited by 10
Jiangzhi Capsule improves fructose-induced insulin resistance in rats: Association with repair of the impaired sarcolemmal glucose transporter-4 recycling
Jiang, L., Yao, L., Yang, Y., Ke, D., Batey, R. G., Wang, J., & Li, Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.09.009 · Cited by 11
Distinct Influence of Hypercaloric Diets Predominant with Fat or Fat and Sucrose on Adipose Tissue and Liver Inflammation in Mice
da Fonseca, C. S. M., Basford, J. E., Kuhel, D. G., Konaniah, E. S., Cash, J. G., Lima, V. L. D. M., & Hui, D. Y. (2020) · Molecules · doi:10.3390/molecules25194369 · Cited by 11
miR-23b Ameliorates nonalcoholic steatohepatitis by targeting Acyl-CoA thioesterases 4
Li, H., Li, X., Yu, S., Hu, Y., Xu, L., Wang, T., Yang, X., Sun, X., & Zhao, B. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112787 · Cited by 10
Translational Control in Liver Disease
Balvey, A., & Fernández, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.795298 · Cited by 10
In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained
Hano, H., Takasaki, S., Kobayashi, H., Koyama, T., Lu, T., & Nagatsuma, K. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1402-8 · Cited by 10
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
Corey, K. E., & Chalasani, N. (2011) · Hepatology · doi:10.1002/hep.24696 · Cited by 10
Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic fat of NAFLD Model in Rats
Eslami, Z., Moghanlou, A. E., Kandi, Y. M., Arabi, M. S., Norouzi, A., & Joshaghani, H. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_21_22 · Cited by 9
Nicotine aggravates high-fat diet-induced non-alcoholic fatty liver disease in mice via inhibition of CISD3
Wei, Y.-F., Pan, T., Zhao, Y., Chen, Z., Wu, L., Wang, X., Wang, X., Wang, X., Chen, D., & Chen, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113067 · Cited by 10
Natural linoleic acid from marine fungus Eutypella sp. F0219 blocks KEAP1/NRF2 interaction and ameliorates MASLD by targeting FABP4
Wu, C., Chen, Y., Chen, M., Fu, T., Liu, J., Liu, F., Xu, C., Li, W.-S., Li, B.-L., Jiang, Z.-P., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.019 · Cited by 9
Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
Gangitano, E., Scannapieco, F., Lubrano, C., & Gnessi, L. (2024) · Livers · doi:10.3390/livers4040038 · Cited by 10
Zhuyu pill attenuates metabolic-associated fatty liver disease by regulating macrophage polarization through TLR4 signaling pathway
Zhao, M., He, Q., Shu, X., Xu, R., Zhang, Z., Mou, Y., Liao, W., Zhang, Y., Zhou, Z., & Shen, T. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156439 · Cited by 9
Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease: review
Bekheit, M., Kamera, B. S., Colacino, L., Dropmann, A., Delibegović, M., Almadhoob, F., Hanafy, N. A. N., Bermano, G., & Hammad, S. (2024) · EXCLI journal · doi:10.17179/excli2024-7718 · Cited by 12
Glycogen Synthase Kinase 3 β Hepatocyte Deletion Attenuates Ferroptosis and Metabolic Dysfunction-associated Steatohepatitis in Mice
Warasnhe, K., Sano, A., Guo, Q., Satthawiwat, N., Dai, X., Classon, P., Meroueh, C., Lee, H. S. K., Valenzuela-Pérez, L., Victorelli, S. G., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101633 · Cited by 10
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial
Li, X., Benegiamo, G., Vijayakumar, A., SRODA, N., Kimura, M., Huss, R. S., WENG, S., Murakami, E., Kirby, B. J., von Alvensleben, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04169-6 · Cited by 10
Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia
Caballería, L., Saló, J., Berzigotti, A., Planas, R., Vila, M. C., Huertas, C., Torres, M., Torán‐Monserrat, P., & Caballería, J. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.03.005 · Cited by 11
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
Møller, S., Kimer, N., Kronborg, T. M., Grandt, J., Hove, J. D., Barloese, M. C. J., & Gluud, L. L. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1725022 · Cited by 10
The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
Yang, Y., Li, S., Xu, Y., Ke, J., & Zhao, D. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s350579 · Cited by 9
Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD)
Ran, Q., Gan, Q., Zhu, Y., Li, S., Shen, L., Duan, X., Zhu, X., & Huang, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116322 · Cited by 10
The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
Kim, M. Y. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.6.341 · Cited by 9
Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice
Zhang, M., Xie, Z., Zhang, R., Chen, D.-K., Gu, M., Cui, S., Zhang, Y., Zhang, X., Yu, Y., Li, J. X., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.186 · Cited by 9
Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway
Wang, X., Dong, L., Gai, Q., Ai, W., Wu, Y. S., Xiao, W., Zhang, J., & An, W. (2020) · Hepatology Communications · doi:10.1002/hep4.1532 · Cited by 8
A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01423-3 · Cited by 9
Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease
Xu, Y., Lu, L., Liu, S., Du, S.-X., Zhu, H., Dong, Q., & Xin, Y. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.04.004 · Cited by 9
Glabridin ameliorates intracellular events caused by palmitic acid and alcohol in mouse hepatocytes and fast food diet and alcohol -induced steatohepatitis and fibrosis in C57BL/6J mice model
Sharma, R. R., Rashid, H., Bhat, A. M., Archoo, S., Gupta, R., & Abdullah, S. T. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114038 · Cited by 8
Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
Yang, X., Yan, H., Guo, R., & Chen, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-90818-2 · Cited by 8
Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction–associated steatotic liver disease progression
Fu, Y., Peng, X., Song, H., Li, X., Zhi, Y., Tang, J. T., Liu, Y., Chen, D., Li, W., Zhang, J., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186478 · Cited by 8
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): data from the NHANES III (1988–1994)
Zhang, Y., Luo, P., Tang, Y.-N., Wang, J., Gao, S., Fan, Y., & Wang, K. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00942-z · Cited by 8
The gut–adipose/pancreas axis: a novel perspective on glycolipid metabolism dysregulation in MAFLD and T2DM pathogenesis
Liang, J., Chen, X., Chu, Y., & Leng, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1664233 · Cited by 9
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Weiskirchen, R., & Lonardo, A. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671694 · Cited by 9
Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
da Fonseca, L. G., Hashizume, P. H. S., de Oliveira, I. S., Izquierdo‐Sánchez, L., Saud, L. R. D. C., Xerfan, M. P., Alves, V. A. F., de Mello, E. S., Herman, P., Bañales, J. M., et al. (2022) · Cancers · doi:10.3390/cancers14143483 · Cited by 9
Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease
Dao-yu, T., Shi, H., Li, C., Zhong, X.-L., & Kang, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5877 · Cited by 8
The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
Jorgačević, B. Z., Vučević, D. B., Djuricic, I. D., Sobajic, S. S., Mladenović, D. R., Vesković, M. N., Ješić-Vukićević, R., & Radosavljević, T. S. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.03.009 · Cited by 8
Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry
Asgharpour, A., Dinani, A. M., & Friedman, S. L. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.01.04 · Cited by 8
Bridelia ferruginea Benth. (Euphorbiaceae) mitigates oxidative imbalance and lipotoxicity, with concomitant modulation of insulin signaling pathways via GLUT4 upregulation in hepatic tissues of diabetic rats
Oyebode, O. A., Erukainure, O. L., Chuturgoon, A. A., Ghazi, T., Naidoo, P., Chukwuma, C. I., & Islam, M. S. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114816 · Cited by 8
Qualitative and Quantitative Changes in Total Lipid Concentration and Lipid Fractions in Liver Tissue of Periparturient German Holstein Dairy Cows of Two Age Groups
Theinert, K. B., Snedec, T., Pietsch, F., Theile, S., Leonhardt, A.-S., Spilke, J., Pichelmann, S., Bannert, E., Reichelt, K., Dobeleit, G., et al. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.814808 · Cited by 8
Effect of Aerobic Exercise on Lipid Metabolism in Rats With NAFLD
Zhou, T., Niu, M., Liu, R., & Li, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.901827 · Cited by 8
Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
Carulli, L., Maurantonio, M., Hebbard, L., Baldelli, E., Loria, P., & George, J. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811319290009 · Cited by 8
Definition, Pathogenesis, and Natural Progress of Non-alcoholic Fatty Liver Disease
Jeon, J., & Park, K. (2014) · Journal of Korean Diabetes · doi:10.4093/jkd.2014.15.2.65 · Cited by 8
Prevalence and Predictor of Nonalcoholic Steatohepatitis (NASH) in Nonalcoholic Fatty Liver Disease (NAFLD)
Alam, S., Alam, M., Alam, S. M. N. E., Chowdhury, Z. R., & Kabir, J. (2015) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v32i2.26034 · Cited by 8
Senna alata leaf extract restores insulin sensitivity in high-fat diet-induced obese mice
Naowaboot, J., & Piyabhan, P. (2016) · Clinical Phytoscience · doi:10.1186/s40816-016-0032-5 · Cited by 8
A mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4.
Ma, P., Yao, L., Lin, X., Gu, T., Rong, X., Batey, R. G., Yamahara, J., Wang, J., & Li, Y. (2016) · PubMed Central · Cited by 8
Evaluating the Influence of Side Stream Cigarette Smoke at an Early Stage of Non-Alcoholic Steatohepatitis Progression in Mice
Kim, J. W., Yun, H., Choi, S., Lee, S. H., Park, S., Lim, C. W., Lee, K., & Kim, B. (2017) · Toxicological Research · doi:10.5487/tr.2017.33.1.031 · Cited by 8
Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes
Romero-Ibarguengoitia, M. E., Herrera-Rosas, A., Domínguez-Mota, A. A., Camas-Benitez, J. T., Serratos-Canales, M. F., León-Hernández, M., González-Chávez, A., López‐Ortiz, E., Mummidi, S., Duggirala, R., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000900 · Cited by 8
Programming of hepatic lipid metabolism in a rat model of postnatal nicotine exposure – Sex-related differences
Bertasso, I. M., Pietrobon, C. B., Lopes, B. P., Peixoto, T. C., Soares, P. N., OLIVEIRA, E. B. D., Manhães, A. C., Bonfleur, M. L., Balbo, S. L., Cabral, S. S., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113781 · Cited by 8
Fatty Liver Disease
TINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 7
Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
Zhang, Y., Wang, T., Han, J., Song, J., Yang, C., Liang, L., Li, H., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1610498 · Cited by 9
The inflammatory index and cytokines are associated with non-alcoholic fatty liver disease in type 2 diabetes mellitus
Liu, R., Liu, R., Liu, M., Tian, Y., Liu, J., Wang, Y., Sui, Q., Zhang, J., Xu, H., & Qi, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1659998 · Cited by 7
The heterogeneity of monocyte-derived macrophages in MASH pathogenesis
Zhang, M., Xia, E., Li, C., Ma, S., Yang, F., Tian, S., Zhou, X., Zheng, X., Li, B., Yang, H. J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02562-9 · Cited by 8
Nutritional Composition and Effect of Loquat Fruit (Eriobotrya japonica L. var. Navela) on Lipid Metabolism and Liver Steatosis in High-Fat High-Sucrose Diet-Fed Mice
Mokhtari, I., Moumou, M., Mokhtari, C., Harnafi, M., Milenković, D., Amrani, S., & Harnafi, H. (2024) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2024.29.3.256 · Cited by 7
Exogenous Mitochondrial Pretreatment Enhances the Therapeutic Effect of UC‐MSCs on NAFLD in Type 2 Diabetic Mice by Mediating Mitochondrial Transfer
Hu, R., Zhao, J., Cheng, Y., Su, W., Ren, R., Zhang, H., Zhang, Y., Wang, A., Mu, Y., & Yu, S. (2025) · Stem Cells International · doi:10.1155/sci/4639115 · Cited by 7
Accurate quantification of hepatic fat—is it important?
Adams, L. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.23 · Cited by 7
1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease
Ibrahim, M., Khalefa, A. A., Hemead, D. A., Alsemeh, A. E., & Habib, M. A. (2023) · Journal of Molecular Histology · doi:10.1007/s10735-023-10118-9 · Cited by 7
Cholesterol dynamics in rabbit liver: High-fat diet, olive oil, and synergistic dietary effects
Funes, A. K., Avena, V., Boarelli, P. V., Monclus, M. A., Fernández, D., Lancellotti, T. E. S., & Fornés, M. W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150675 · Cited by 8
Consequences of PPARαInvalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids
Guelzim, N., Huneau, J., Mathé, V., Quignard‐Boulangé, A., Martin, P. G. P., Tomé, D., & Hermier, D. (2011) · PPAR Research · doi:10.1155/2011/256186 · Cited by 7

Authors: Neuschwander‐Tetri, B. A.
Affiliations: Saint Louis University (US)
Corresponding author: Neuschwander‐Tetri, Brent A.
ORCID: Neuschwander‐Tetri, Brent A.
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-08
Volume: 52
Issue: 2
Pages: 774-788
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.23719
OpenAlex: W2107943478
Cited by: 1,077
References: 196
Citations by year: 2026: 29 · 2025: 61 · 2024: 66 · 2023: 78 · 2022: 75 · 2021: 86 · 2020: 106 · 2019: 72 · 2018: 66 · 2017: 72 · 2016: 77 · 2015: 60 · 2014: 64 · 2013: 52 · 2012: 47
FWCI: 5.87
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1857 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: nonalcoholic steatohepatitis, hepatic lipotoxicity, NASH pathogenesis, triglyceride accumulation, insulin resistance, de novo lipogenesis, adipose tissue insulin sensitivity, lipolysis, carbohydrate intake, physical activity, muscle glucose uptake
MeSH terms: Fatty Acids, Fatty Liver, Humans, Insulin Resistance, Liver, Causality, Oxidative Stress, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks